SCHEMBL21792393

SCHEMBL21792393

CC(C)(C)OC=C1C(=O)CC(c2ccccc2)CC1=O

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAP1LC3B Q9GZQ8 7/20 0.56
▸ MEN1 O00255 3/20 0.53
▸ KMT2A Q03164 3/20 0.53
▸ GAA P10253 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ AKR1C2 P52895 1/20 0.41
▸ AKR1C1 Q04828 1/20 0.41
▸ HTT P42858 1/20 0.40
▸ ADORA2A P29274 1/20 0.40
▸ LMNA P02545 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ HSP90AA1 P07900 1/20 0.39
▸ HSP90AB1 P08238 1/20 0.39
▸ LDHA P00338 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ BRD4 O60885 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21792641 0.77 MAP1LC3B (0.40) MAP1LC3BMEN1KMT2AGAAMAPT
SCHEMBL21795161 0.76 MAP1LC3B (0.67) MAP1LC3BMEN1KMT2AGAAMAPT
SCHEMBL21792396 0.75 MAP1LC3B (0.56) MAP1LC3BMEN1KMT2AGAAMAPT
SCHEMBL21774000 0.73 MAP1LC3B (0.62) MAP1LC3BMEN1KMT2AGAAMAPT
SCHEMBL21821646 0.73 MAP1LC3B (0.62) MAP1LC3BMEN1KMT2AGAAMAPT
SCHEMBL26522054 0.72 MAP1LC3B (0.61) MAP1LC3BMEN1KMT2AGAAMAPT
SCHEMBL21821730 0.72 MAP1LC3B (0.61) MAP1LC3BMEN1KMT2AGAAMAPT
SCHEMBL1780317 0.72 MAP1LC3B (1.00) MAP1LC3BMEN1KMT2AGAAMAPT
SCHEMBL21821905 0.72 MAP1LC3B (0.56) MAP1LC3BMEN1KMT2AGAAMAPT
SCHEMBL21821899 0.71 MAP1LC3B (0.60) MAP1LC3BMEN1KMT2AGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11021457-B2 Class of isoindolone-imide ring-1,3-dione-2-ene compounds, composition and use thereof Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2021-06-01 — — US disclosed
US-20200071291-A1 A CLASS OF ISOINDOLONE-IMIDE RING-1,3-DIONE-2-ENE COMPOUNDS, COMPOSITION AND USE THEREOF Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2020-03-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200071291-A1 A CLASS OF ISOINDOLONE-IMIDE RING-1,3-DIONE-2-ENE COMPOUNDS, COMPOSITION AND USE THEREOF ATG7, MLST8, BECN1 MAP1LC3B 17/4885MEN1 2613/4885KMT2A 2758/4885
US-11021457-B2 Class of isoindolone-imide ring-1,3-dione-2-ene compounds, composition and use thereof ATG7, MLST8, BECN1 MAP1LC3B 14/4885MEN1 2872/4885KMT2A 2696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback